Incyte Corp. (INCY)
105.95
+2.52
(+2.44%)
USD |
NASDAQ |
Jan 14, 16:00
105.70
-0.25
(-0.24%)
Pre-Market: 08:02
Incyte Market Cap: 20.80B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 960.61B |
| Pfizer Inc. | 145.44B |
| Bio-Techne Corp. | 10.66B |
| Xencor, Inc. | 1.032B |
| Halozyme Therapeutics, Inc. | 8.580B |
Market Cap Related Metrics
| PE Ratio | 17.77 |
| PS Ratio | 4.379 |
| PEG Ratio | 0.0043 |
| Price to Book Value | 4.472 |
| Price to Free Cash Flow | 17.98 |
| Price | 105.95 |
| Earnings Yield | 5.63% |
| PEGY Ratio | 0.0043 |
| Operating PE Ratio | 16.78 |
| Normalized PE Ratio | 20.53 |